FDA Inspection 702362 — Cispharma Inc.

Cispharma Inc. — FEI 3008276856

The FDA completed an inspection of Cispharma Inc. on Jan 24, 2011 in Cranbury, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 15 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jan 24, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Cranbury, NJ (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
117721 CFR 211.63Equipment Design, Size and Location
121521 CFR 211.67(b)Written procedures not established/followed
126321 CFR 211.68(b)Computer control of master formula records
136121 CFR 211.100(a)Absence of Written Procedures
179021 CFR 211.80(b)Handling and Storage to Prevent Contamination
180221 CFR 211.84(b)Representative Samples
181021 CFR 211.160(a)Lab controls established, including changes
202821 CFR 211.192Extent of discrepancy, failure investigations
355721 CFR 211.52Washing and toilet facilities are deficient
358521 CFR 211.110(a)Control procedures to monitor and validate performance
430721 CFR 211.80(d)Status of Each Lot Identified
431121 CFR 211.84(c)(4)Compositing of Sub Samples
431521 CFR 211.84(d)(2)Testing Each Component for Conformity with Specs
433021 CFR 211.130(e)Packaging line inspection documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.